{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:41:54Z","timestamp":1784126514080,"version":"3.55.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T00:00:00Z","timestamp":1743897600000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Antidepressants are used by 60% of residents of long-term care facilities (LTCFs). Mirtazapine and sertraline are the most commonly used antidepressants, despite little safety information for their use in LTCFs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To investigate risk of adverse outcomes (falls, fractures, cardiovascular-, dementia-, and delirium-related hospitalisations, all-cause mortality) associated with mirtazapine compared to sertraline use post-LTCF entry.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Active new user retrospective cohort study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Subjects<\/jats:title>\n                  <jats:p>Individuals aged 65\u2013105\u00a0years entering LTCFs in three Australian states during 1 January 2015 to 31 October 2018, who initiated mirtazapine or sertraline \u226460\u00a0days post-LTCF entry, with follow-up to 31 December 2019.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The inverse probability of treatment weighting of individuals\u2019 propensity scores was used to adjust Cox and Fine\u2013Gray regression models to estimate the risk of outcomes of interest associated with mirtazapine compared to sertraline use in LTCFs. Weighted (adjusted) hazard ratios (aHRs), subdistribution hazard ratios and 95% confidence intervals (95% CIs) are presented.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 5409 residents initiated mirtazapine (71%, n\u2009=\u20093837) or sertraline (29%, n\u2009=\u20091572) post-LTCF entry. After weighting, mirtazapine was associated with a higher risk of mortality (aHR 1.16, 95% CI 1.05\u20131.29) compared to sertraline. The risk of falls and fractures within 90\u00a0days was not statistically significantly different between the groups but was lower in mirtazapine users thereafter. No differences in risk of cardiovascular-, dementia- or delirium-related hospitalisations were observed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Compared to sertraline, mirtazapine use is associated with a higher risk of mortality and, after 90\u00a0days of use, a lower risk of falls and fractures. This risk of harm should be balanced with limited evidence for effectiveness when considering antidepressant therapy in LTCFs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ageing\/afaf074","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T19:36:16Z","timestamp":1743968176000},"source":"Crossref","is-referenced-by-count":6,"title":["Risk of adverse outcomes associated with mirtazapine compared to sertraline use among older people living in long-term care facilities"],"prefix":"10.1093","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9938-1912","authenticated-orcid":false,"given":"Georgina A","family":"Hughes","sequence":"first","affiliation":[{"name":"University of South Australia , UniSA Clinical & Health Sciences, Adelaide, South Australia,","place":["Australia"]},{"name":"Registry of Senior Australians Research Centre , South Australian Health and Medical Research Institute, Adelaide, South Australia,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8261-2665","authenticated-orcid":false,"given":"Maria C","family":"Inacio","sequence":"additional","affiliation":[{"name":"Registry of Senior Australians Research Centre , Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Bedford Park, South Australia,","place":["Australia"]},{"name":"University of South Australia , UniSA Allied Health & Human Performance, Adelaide, South Australia,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Rowett","sequence":"additional","affiliation":[{"name":"Drug and Therapeutics Information Service , Southern Adelaide Local Health Network, Adelaide, South Australia,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1192-4121","authenticated-orcid":false,"given":"Gillian E","family":"Caughey","sequence":"additional","affiliation":[{"name":"Registry of Senior Australians Research Centre , South Australian Health and Medical Research Institute, Adelaide, South Australia,","place":["Australia"]},{"name":"Registry of Senior Australians Research Centre , Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Bedford Park, South Australia,","place":["Australia"]},{"name":"University of South Australia , UniSA Allied Health & Human Performance, Adelaide, South Australia,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Air","sequence":"additional","affiliation":[{"name":"Registry of Senior Australians Research Centre , South Australian Health and Medical Research Institute, Adelaide, South Australia,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine E","family":"Lang","sequence":"additional","affiliation":[{"name":"Registry of Senior Australians Research Centre , South Australian Health and Medical Research Institute, Adelaide, South Australia,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Corlis","sequence":"additional","affiliation":[{"name":"Australian Nursing & Midwifery Federation SA Branch , Adelaide, South Australia,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9059-5209","authenticated-orcid":false,"given":"Janet K","family":"Sluggett","sequence":"additional","affiliation":[{"name":"Registry of Senior Australians Research Centre , South Australian Health and Medical Research Institute, Adelaide, South Australia,","place":["Australia"]},{"name":"University of South Australia , UniSA Allied Health & Human Performance, Adelaide, South Australia,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,6]]},"reference":[{"key":"2025040619360852100_ref1","doi-asserted-by":"publisher","first-page":"104957","DOI":"10.1016\/j.jamda.2024.01.026","article-title":"National trends in antidepressant use in Australian residential aged care facilities (2006\u20132019)","volume":"25","author":"Hughes","year":"2024","journal-title":"J Am Med Dir Assoc"},{"key":"2025040619360852100_ref2","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.jamda.2021.12.043","article-title":"Potential unintended consequences of antipsychotic reduction in Ontario nursing homes","volume":"23","author":"Harris","year":"2022","journal-title":"J Am Med Dir Assoc"},{"key":"2025040619360852100_ref3","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/pds.5341","article-title":"Use of sedating medications around nursing home admission in Denmark","volume":"30","author":"Potteg\u00e5rd","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2025040619360852100_ref4","volume-title":"Major Depression","author":"Therapeutic Guidelines Limited"},{"key":"2025040619360852100_ref5","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s40266-012-0003-6","article-title":"The use of antidepressants in Belgian nursing homes","volume":"29","author":"Bourgeois","year":"2012","journal-title":"Drugs Aging"},{"key":"2025040619360852100_ref6","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1080\/13607863.2020.1849021","article-title":"Changes in depressive symptoms and cognitive impairment in older long-stay nursing home residents in the USA: a latent transition analysis","volume":"25","author":"Yuan","year":"2021","journal-title":"Aging Ment Health"},{"key":"2025040619360852100_ref7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S1525-8610(04)70063-8","article-title":"Mirtazapine is associated with less anxiolytic use among elderly depressed patients in long-term care facilities","volume":"5","author":"Gardner","year":"2004","journal-title":"J Am Med Dir Assoc"},{"key":"2025040619360852100_ref8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006528.pub2","article-title":"Mirtazapine versus other antidepressive agents for depression","volume":"12","author":"Watanabe","journal-title":"Cochrane Database Syst Rev"},{"key":"2025040619360852100_ref9","volume-title":"Clinical Practice Guidelines for the Appropriate Use of Psychotropic Medications in People Living with Dementia and in Residential Aged Care","author":"The Guideline Development Group","year":"2022"},{"key":"2025040619360852100_ref10","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/01.JGP.0000308883.64832.ed","article-title":"Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence","volume":"16","author":"Nelson","year":"2008","journal-title":"Am J Geriatr Psychiatry"},{"key":"2025040619360852100_ref11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jad.2012.02.036","article-title":"Efficacy of treatment in older depressed patients: a systematic review and meta-analysis of double-blind randomized controlled trials with antidepressants","volume":"141","author":"Kok","year":"2012","journal-title":"J Affect Disord"},{"key":"2025040619360852100_ref12","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jamda.2011.08.009","article-title":"A review of the effectiveness of antidepressant medications for depressed nursing home residents","volume":"13","author":"Boyce","year":"2012","journal-title":"J Am Med Dir Assoc"},{"key":"2025040619360852100_ref13","doi-asserted-by":"publisher","first-page":"CD003491","DOI":"10.1002\/14651858.CD003491.pub2","article-title":"Antidepressants for depressed elderly","volume":"2006","author":"Mottram","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"2025040619360852100_ref14","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.1002\/hup.470100807","article-title":"Org 3770 (mirtazapine) versus trazodone: a placebo controlled trial in depressed elderly patients","volume":"10","author":"Halikas","year":"1995","journal-title":"Hum Psychopharmacol"},{"key":"2025040619360852100_ref15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1600-0447.1996.tb10629.x","article-title":"A double-blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients","volume":"93","author":"Hsy\u00f8erg","year":"1996","journal-title":"Acta Psychiatr Scand"},{"key":"2025040619360852100_ref16","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/00019442-200209000-00007","article-title":"Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients","volume":"10","author":"Schatberg","year":"2002","journal-title":"Am J Geriatr Psychiatry"},{"key":"2025040619360852100_ref17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/VPDT7105","article-title":"A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer\u2019s disease and agitated behaviours: the HTA-SYMBAD trial","volume":"27","author":"Banerjee","year":"2023","journal-title":"Health Technol Assess"},{"key":"2025040619360852100_ref18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0140-6736(11)60830-1","article-title":"Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial","volume":"378","author":"Banerjee","year":"2011","journal-title":"Lancet"},{"key":"2025040619360852100_ref19","doi-asserted-by":"publisher","first-page":"d4551","DOI":"10.1136\/bmj.d4551","article-title":"Antidepressant use and risk of adverse outcomes in older people: population based cohort study","volume":"343","author":"Coupland","year":"2011","journal-title":"BMJ"},{"key":"2025040619360852100_ref20","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/clpt.2011.54","article-title":"Antidepressants and fracture risk in older adults: a comparative safety analysis","volume":"89","author":"Gagne","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"2025040619360852100_ref21","doi-asserted-by":"publisher","first-page":"e0215289","DOI":"10.1371\/journal.pone.0215289","article-title":"Antidepressants and the risk of death in older patients with depression: a population-based cohort study","volume":"14","author":"Kollhorst","year":"2019","journal-title":"PLoS One"},{"key":"2025040619360852100_ref22","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1185\/030079903125002441","article-title":"Mirtazapine in the nursing home study group. Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home","volume":"19","author":"Roose","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"2025040619360852100_ref23","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/gps.1589","article-title":"Mirtazapine orally disintegrating tablets in depressed nursing home residents 85 years of age and older","volume":"21","author":"Nelson","year":"2006","journal-title":"Int J Geriatr Psychiatry"},{"key":"2025040619360852100_ref24","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/gps.1779","article-title":"Are there predictors of outcome in depressed elderly nursing home residents during treatment with mirtazapine orally disintegrating tablets?","volume":"22","author":"Nelson","year":"2007","journal-title":"Int J Geriatr Psychiatry"},{"key":"2025040619360852100_ref25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s40471-015-0053-5","article-title":"The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application","volume":"2","author":"Lund","year":"2015","journal-title":"Curr Epidemiol Rep"},{"key":"2025040619360852100_ref26","doi-asserted-by":"publisher","first-page":"e066390","DOI":"10.1136\/bmjopen-2022-066390","article-title":"Registry of Senior Australians (ROSA): integrating cross-sectoral information to evaluate quality and safety of care provided to older people","volume":"12","author":"Inacio","year":"2022","journal-title":"BMJ Open"},{"key":"2025040619360852100_ref27","volume-title":"ATC\/DDD Index 2024","author":"World Health Organization Collaborating Centre for Drug Statistics Methodology"},{"key":"2025040619360852100_ref28","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/intqhc\/mzaa078","article-title":"The Registry of Senior Australians outcome monitoring system: quality and safety indicators for residential aged care","volume":"32","author":"Inacio","year":"2020","journal-title":"Int J Qual Health Care"},{"key":"2025040619360852100_ref29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-0500-6-128","article-title":"Transient ischaemic attack and ischaemic stroke: constructing episodes of care using hospital claims data","volume":"6","author":"Sluggett","year":"2013","journal-title":"BMC Res Notes"},{"key":"2025040619360852100_ref30","doi-asserted-by":"publisher","first-page":"100692","DOI":"10.1016\/j.lanwpc.2023.100692","article-title":"Sex differences in risk of cardiovascular events and mortality with sodium glucose co-transporter-2 inhibitors versus glucagon-like peptide 1 receptor agonists in Australians with type 2 diabetes: a population-based cohort study","volume":"33","author":"Sharma","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"2025040619360852100_ref31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00228-011-1087-3","article-title":"New users of antidepressant medications: first episode duration and predictors of discontinuation","volume":"68","author":"Lu","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"2025040619360852100_ref32","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/pds.3459","article-title":"Assigning exposure duration to single prescriptions by use of the waiting time distribution","volume":"22","author":"Potteg\u00e5rd","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2025040619360852100_ref33","doi-asserted-by":"publisher","first-page":"e021122","DOI":"10.1136\/bmjopen-2017-021122","article-title":"The validity of the Rx-risk comorbidity index using medicines mapped to the Anatomical Therapeutic Chemical (ATC) classification system","volume":"8","author":"Pratt","year":"2018","journal-title":"BMJ Open"},{"key":"2025040619360852100_ref34","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2217\/cer-2020-0013","article-title":"Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulants","volume":"9","author":"Allan","year":"2020","journal-title":"J Comp Eff Res"},{"key":"2025040619360852100_ref35","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"2025040619360852100_ref36","volume-title":"Patient-Centred Outcome Measures Sets","author":"International Consortium for Health Outcomes Measurement"},{"key":"2025040619360852100_ref37","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/bcp.12829","article-title":"Antidepressants and antipsychotics classified with torsades de pointes arrhythmia risk and mortality in older adults\u2014a Swedish Nationwide study","volume":"81","author":"Danielsson","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"2025040619360852100_ref38","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.jad.2020.01.021","article-title":"Predictors of mortality in people with late-life depression: a retrospective cohort study","volume":"266","author":"Cai","year":"2020","journal-title":"J Affect Disord"},{"key":"2025040619360852100_ref39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12916-022-02247-x","article-title":"The risk of all-cause and cause-specific mortality in people prescribed mirtazapine: an active comparator cohort study using electronic health records","volume":"20","author":"Joseph","year":"2022","journal-title":"BMC Med"},{"key":"2025040619360852100_ref40","volume-title":"Pharmaceutical Benefits Scheme (PBS) Expenditure and Prescriptions Report 1 July 2022 to 30 June 2023","author":"Australian Government Department of Health and Aged Care","year":"2023"},{"key":"2025040619360852100_ref41","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.jagp.2017.08.014","article-title":"Association between antidepressants and fall-related injuries among long-term care residents","volume":"25","author":"Macri","year":"2017","journal-title":"Am J Geriatr Psychiatry"},{"key":"2025040619360852100_ref42","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1186\/s12877-021-02640-w","article-title":"The risk of fall-related hospitalisations at entry into permanent residential aged care","volume":"21","author":"Inacio","year":"2021","journal-title":"BMC Geriatr"},{"key":"2025040619360852100_ref43","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1177\/0091270011405665","article-title":"New insights: dose-response relationship between psychotropic drugs and falls: a study in nursing home residents with dementia","volume":"52","author":"Sterke","year":"2012","journal-title":"J Clin Pharmacol"},{"key":"2025040619360852100_ref44","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1093\/gerona\/glr113","article-title":"Antidepressant prescriptions: an acute window for falls in the nursing home","volume":"66A","author":"Berry","year":"2011","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2025040619360852100_ref45","doi-asserted-by":"publisher","first-page":"e2435535","DOI":"10.1001\/jamanetworkopen.2024.35535","article-title":"Injurious fall risk differences among older adults with first-line depression treatments","volume":"7","author":"Wang","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2025040619360852100_ref46","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s41999-021-00475-7","article-title":"Depression, antidepressants and fall risk: therapeutic dilemmas\u2014a clinical review","volume":"12","author":"Poelgeest","year":"2021","journal-title":"Eur Geriatr Med"},{"key":"2025040619360852100_ref47","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.amjopharm.2009.07.001","article-title":"Determinants of antidepressant medication prescribing in elderly residents of aged care homes in Australia: a retrospective study","volume":"7","author":"Nishtala","year":"2009","journal-title":"Am J Geriatr Pharmacother"},{"key":"2025040619360852100_ref48","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1176\/appi.ps.58.1.34","article-title":"A comparison of factors used by physicians and patients in the selection of antidepressant agents","volume":"58","author":"Gardner","year":"2007","journal-title":"Psychiatr Serv"},{"key":"2025040619360852100_ref49","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/aje\/kwae136","article-title":"Medication management in long-term care: using evidence generated from real-world data to effect policy change in the Australian setting","volume":"193","author":"Sluggett","year":"2024","journal-title":"Am J Epidemiol"},{"key":"2025040619360852100_ref50","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1071\/AH22049","article-title":"Government-subsidised mental health services are underused in Australian residential aged care facilities","volume":"46","author":"Cations","year":"2022","journal-title":"Aust Health Rev"}],"container-title":["Age and Ageing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/54\/4\/afaf074\/62874557\/afaf074.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/54\/4\/afaf074\/62874557\/afaf074.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T19:36:33Z","timestamp":1743968193000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ageing\/article\/doi\/10.1093\/ageing\/afaf074\/8106798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,3,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ageing\/afaf074","relation":{},"ISSN":["0002-0729","1468-2834"],"issn-type":[{"value":"0002-0729","type":"print"},{"value":"1468-2834","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2025,3,28]]},"article-number":"afaf074"}}